The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.
Mark Argentine
Advertisement
Mark Argentine is a senior research advisor at Eli Lilly.
Articles by Mark Argentine
A risk-based approach is recommended for analytical method comparability for HPLC assay and impurities methods.
Advertisement
Latest Updated Articles
Analytical Method Comparability in Registration and Post-Approval Stages: A Risk-Based ApproachPublished: October 2nd 2014 | Updated:
Evaluating Progress in Analytical Quality by DesignPublished: April 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using A Streamlined Workflow to Identify Particulates in Biologic Drugs
2
How 3D-Printed Tablets Can Optimize IgA Nephropathy Treatment
3
Defining An Agitation Model for Early-Stage, High Concentration Biologics Formulation Development
4
AI-Powered Digital Twins Achieve High Accuracy in Human Lung Function Forecasting
5
